A randomized non-inferiority study evaluating the efficacy of 2 commercially available teat sealants in dairy cows
JOURNAL OF DAIRY SCIENCE(2022)
摘要
The primary objective of this study was to compare the efficacy of a new internal teat sealant (ShutOutTM, Merck Animal Health, Madison, NJ) (SO) to the current U.S. industry leader (Orbeseal®, Zoetis, Parsippany, NJ) (ORB). This comparison was based on a non-inferiority evaluation of quarter-level new infection risk during the dry period, with secondary comparisons of cure risk, incidence of clinical mastitis at the cow level during the first 120 days in milk, as well as cow-level performance in early lactation based on milk production, somatic cell count (SCC), and risk for removal from the herd.
更多查看译文
关键词
mastitis, teat sealant
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要